Richard U. de Schutter, Director at Valeant Pharmaceuticals International, Inc. (VRX), bought 11,344 shares at $21.80 ($249K) on 2018-05-15, disclosed to the SEC on 2018-07-03.
Open-market purchase of $249k VRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.80 | 10,000 | $218K | 87.5% |
| 2 | $23.24 | 1,344 | $31K | 12.5% |
| Total | $21.97 avg | 11,344 | $249K | 100% |
| Filing → |
| BHC | BUY | 2018-09-17 | $3.0M | — | Filing → |
| VRX | BUY | 2018-05-17 | $327K | — | Filing → |
| VRX | BUY | 2018-03-12 | $153K | — | Filing → |